Contact

All Stories

  1. MOLECULAR CHARACTERIZATION, CLINICAL MANAGEMENT AND DEVELOPMENT OF THE VACCINES AGAINST THE TARGETED VIRAL COMPONENTS OF COVID-19

    Article • Military Medical Science Letters, June 2025, Faculty of Military Health Sciences, University of Defence

    Dr. Taha Nazir

  2. CRISPR/CAS Genome Editing Technology: Implications And Challenges

    Article • April 2024, MDPI AG

    Dr. Taha Nazir

  3. CRISPR-Cas Associated Cells and Animal Mediated Biomedical Modelling

    Article • February 2024, MDPI AG

    Dr. Taha Nazir

  4. Crispr-cas System: Classification, Benefits, Applications And Function

    Article • February 2024, MDPI AG

    Dr. Taha Nazir

  5. CRISPR/CAS Genome Editing Technology: Implications And Challenges

    Article • January 2024, MDPI AG

    Dr. Taha Nazir

  6. Gene Editing, Indiscriminate Degradation And Recyclic Catalytic Events In Crispr Cas Technology

    Article • January 2024, MDPI AG

    Dr. Taha Nazir

  7. History, Development and Characteristics of CRISPR-Cas System

    Article • January 2024, MDPI AG

    Dr. Taha Nazir

  8. The Role of Pro-Inflammatory Mediator Interleukin-32 in Osteoclast Differentiation

    Article • Turkish Journal of Pharmaceutical Sciences, May 2023, Journal of Clinical Research of Pediatric Endocrinology

    Dr. Taha Nazir

  9. THE APPOINTMENTS OF RETIRED GOVERNMENT OFFICES/ PROFESSORS IN PRIVATE PHARMACY INSTITUTIONS IS POTENTIALLY HURTING THE HEALTH CARE SYSTEM AND EDUCATION STANDARDS IN PAKISTAN.

    Article • Pharmaceutical Review, January 2021, Pharmaceutical Review

    Dr. Taha Nazir

  10. AN AMAZING CHARACTER REVEALING THE FUNDAMENTAL FACTORS HURTING THE HEALTH STANDARDS, PHARMACEUTICAL PATIENT'S CARE AND TEACHING QUALITY IN DEVELOPING COUNTRIES.

    Article • Pharmaceutical Review, January 2021, Pharmaceutical Review

    Dr. Taha Nazir

  11. The Innovative Potential of Antibody Engineering Enhanced the Clinical Value of Immunotherapy

    Article • Journal of Pharmaceutical Research International, January 2020, Sciencedomain International

    Dr. Taha Nazir

  12. LEST WE FORGET TO OUR LEGEND HEROES

    Article • Pharmaceutical Review, January 2020, Pharmaceutical Review

    Dr. Taha Nazir

  13. Article • Pakistan Journal of Pharmaceutical Sciences, November 2019, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi

    Dr. Taha Nazir

  14. YOU WILL ALWAYS BE IN OUR HEART AND MEMORIES

    Article • Pharmaceutical Review, January 2019, Pharmaceutical Review

    Dr. Taha Nazir

  15. M. IQBAL (LATE) - GREAT LEADER, SKILLED PHARMACIST AND OUTSTANDING PERSON.

    Article • Pharmaceutical Review, January 2019, Pharmaceutical Review

    Dr. Taha Nazir

  16. The corruption of Dean Pharmacy, University of Sargodha need attention and appropriate investigation

    Article • Pharmaceutical Review, January 2018, Pharmaceutical Review

    Dr. Taha Nazir

  17. ROLE OF CHITOSAN, CARBOXY METHYL CELLULOS, POLYVINYL PYRROLIDONE, KYRON T134 AND PRIMOGEL TO DESIGN THE MOUTH DISINTEGRATING TELMISARTAN TABLET WITH EXTENDED RELEASE PROFILE

    Article • INDONESIAN JOURNAL OF PHARMACY, June 2017, Universitas Gadjah Mada

    Dr. Taha Nazir

  18. The appropriate, true and timely enforcement of Schedule-G of Punjab Drug Rule 2007 is the dream of experts, demand of this age and need of current health care system

    Article • Pharmaceutical Review, January 2017, Pharmaceutical Review

    Dr. Taha Nazir

  19. Review of Administrative and Professional Problems of Pharmacist Community in Current Political Situation of Pakistan

    Article • Pharmaceutical Review, January 2017, Pharmaceutical Review

    Dr. Taha Nazir

  20. The motives, repercussions and potential outcomes of Punjab Drug (Amendment) Bill 2017

    Article • Pharmaceutical Review, January 2017, Pharmaceutical Review

    Dr. Taha Nazir

  21. Insufficient Effort of Punjab Government to Enforce Drug Rules and Improve the Pharmaceutical Care in Province.

    Article • Pharmaceutical Review, January 2017, Pharmaceutical Review

    Dr. Taha Nazir

  22. REVIEW OF DISSIMILAR ROLES, RESPONSIBILITIES AND OFFICIAL DUTIES OF LICENSING (QUALIFIED PERSON) AND EMPLOYEE (WORKING) PHARMACISTS.

    Article • Pharmaceutical Review, January 2017, Pharmaceutical Review

    Dr. Taha Nazir

  23. 8-insufficient-contribution

    Article • Pharmaceutical Review, January 2017, Pharmaceutical Review

    Dr. Taha Nazir

  24. AN EDITORIAL ENTITLED “REVIEW OF EVOLVING ROLE AND POOR REPRESENTATION OF PHARMACY PROFESSIONAL IN PAKISTAN”.

    Article • Pharmaceutical Review, January 2016, Pharmaceutical Review

    Dr. Taha Nazir

  25. Correction of pharmaceutical teaching institution is the start point of professional growth.

    Article • Pharmaceutical Review, January 2016, Pharmaceutical Review

    Dr. Taha Nazir

  26. 6th World Pharmacist Day and Review of Local Professional Situation in Pakistan

    Article • Pharmaceutical Review, January 2016, Pharmaceutical Review

    Dr. Taha Nazir

  27. Analytical review of illegal International Pharmaceutical Conference & Exhibition -2016 (IPCE-2016) and non professional aptitude of pharmacy community in Pakistan.

    Article • Pharmaceutical Review, January 2016, Pharmaceutical Review

    Dr. Taha Nazir

  28. An Analytical Review of 19th International Pharmacy Conference & Exhibition 2016

    Article • Pharmaceutical Review, January 2016, Pharmaceutical Review

    Dr. Taha Nazir

  29. Review of Pharmacy Professionals and Drug Jurisprudence to Achieve the Millennium Development Goals in Punjab Province of Pakistan.

    Article • Indian Journal of Pharmaceutical Education and Research, January 2016, EManuscript Services

    Dr. Taha Nazir

  30. Syed Qalb-e-Hassan Rizvi, president of Pakistan Pharmacist Association (Centre) has disallowed the corruption on behalf of the 19th International Pharmacy Conference & Exhibition (IPCE) 2016.

    Article • Pharmaceutical Review, January 2016, Pharmaceutical Review

    Dr. Taha Nazir

  31. AN UNREST POSED BY SITTING PRESIDENT OF PAKISTAN PHARMACIST ASSOCIATION SYED QULD-E-HASSAN RIZVI UPON THE DISHONEST CORRUPT GANGE

    Article • Pharmaceutical Review, January 2016, Pharmaceutical Review

    Dr. Taha Nazir

  32. Designing, Development and Formulation of Mouth Disintegrating Telmisartan Tablet with Extended Release Profile Using Response Surface Methodology

    Article • Journal of Bioequivalence & Bioavailability, January 2015, OMICS Publishing Group

    Dr. Taha Nazir

  33. Extended Release Orally Disintegrating Dosage Forms are Potential Techniques to Deliver and Maintain the Therapeutic Ranges of Plasma Drug Concentrations

    Article • Journal of Applied Pharmacy, January 2015, OMICS Publishing Group

    Dr. Taha Nazir

  34. Lymphocytopenia; induced by vinorelbine, doxorubicin and cisplatin in human cancer patients

    Article • Breast Disease, January 2015, IOS Press

    Dr. Taha Nazir

  35. Potential Leukocytic Toxicity Induce by Vinorelbine, Doxorubicin and Cisplatin in Human Patients of Breast, Cervix and Lung Cancer

    Article • La Prensa Medica, January 2015, OMICS Publishing Group

    Dr. Taha Nazir

  36. Prudential Review of Pharmaceutical Health Resources in Indian Sub- Continent

    Article • Journal of Health & Medical Informatics, January 2015, OMICS Publishing Group

    Dr. Taha Nazir

  37. Prudential review of pharmacy teaching institutions in Pakistan.

    Article • Pharmaceutical Review, January 2015, Pharmaceutical Review

    Dr. Taha Nazir

  38. The Dilemma of Pharmacy Profession in Pakistan; a "White Paper" Regarding PPA Election 2014

    Article • Pharmaceutical Review, January 2014, Pharmaceutical Review

    Dr. Taha Nazir

  39. Extended method of moment for general population balance models including size dependent growth rate, aggregation and breakage kernels

    Article • Computers & Chemical Engineering, September 2013, Elsevier

    Dr. Taha Nazir

  40. Unwanted outcomes of unprincipled 18th International Pharmacy Conference and Exhibition; 2013

    Article • Pharmaceutical Review, January 2013, Pharmaceutical Review

    Dr. Taha Nazir

  41. Emergence of Potential Superbug Mycobacterium Tuberculosis , Lessons from New Delhi Mutant-1 Bacterial Strains

    Article • International Journal of Health Sciences, January 2012, Al Manhal FZ, LLC

    Dr. Taha Nazir

  42. Simultaneous characterization of multiple properties of solid and liquid phases in crystallization processes using NIR

    Article • Particuology, December 2011, Elsevier

    Dr. Taha Nazir

  43. Isoniazid resistance of Mycobacterium tuberculosis isolated from human patients

    Article • African Journal of Microbiology Research, November 2011, Academic Journals

    Dr. Taha Nazir

  44. Ultrasound spectroscopy and electrical resistance tomography for online characterisation of concentrated emulsions in crossflow membrane emulsifications

    Article • Powder Technology, November 2011, Elsevier

    Dr. Taha Nazir

  45. Avoidable childhood death: A case of mismanagement and inappropriate medication use

    Article • African Journal of Pharmacy and Pharmacology, March 2011, Academic Journals

    Dr. Taha Nazir

  46. Simulation and Optimization of Oxy-Fuel Gas Cycle Power Plant with CO2 Capture

    Article • March 2011, Institute of Electrical & Electronics Engineers (IEEE)

    Dr. Taha Nazir

  47. Pharmaceutical crystal shape control based on online image processing and multi-scale modelling

    Article • International Journal of Modelling Identification and Control, January 2011, Inderscience Publishers

    Dr. Taha Nazir

  48. Ethambutol resistance of indigenous Mycobacterium tuberculosis isolated from human patients

    Article • Brazilian Journal of Microbiology, December 2010, FapUNIFESP (SciELO)

    Dr. Taha Nazir

  49. Effect of seed loading and cooling rate on crystal size and shape distributions in protein crystallization—A study using morphological population balance simulation

    Article • Computers & Chemical Engineering, December 2010, Elsevier

    Dr. Taha Nazir

  50. STAGE IV ACNE A CONSEQUENCE OF SELF MEDICATION/ OVER CONSCIOUSNESS: A CASE REPORT

    Article • Journal of Applied Pharmacy, October 2009, Intellectual Consortium of Drug Discovery and Technology Development Incorporation

    Dr. Taha Nazir

  51. ZINC, COPPER AND IRON LEVEL OF NORMAL AND LOW BIRTH WIEGHT NEONATES AND THEIR RESPECTIVE MOTHERS.

    Article • Journal of Applied Pharmacy, October 2009, Intellectual Consortium of Drug Discovery and Technology Development Incorporation

    Dr. Taha Nazir

  52. THROMOCYTOPENIA INDUCED BY VINORELBINE, DOXURUBICIN AND CISPLATIN IN HUMAN CANCER PATIENTS

    Article • Journal of Applied Pharmacy, July 2009, Intellectual Consortium of Drug Discovery and Technology Development Incorporation

    Dr. Taha Nazir

  53. Polymorphic transformation of l-glutamic acid monitored using combined on-line video microscopy and X-ray diffraction

    Article • Journal of Crystal Growth, August 2006, Elsevier

    Dr. Taha Nazir